RSS
GILD icon

Rosenblum Silverman Sutton’s Gilead Sciences GILD Stock Holding History

Rosenblum Silverman Sutton’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,945
Closed -$675K – 64
2017
Q1 		$675K Sell
9,945
-46,641
-82% -$3.28M 0.29% 55
2016
Q4 		$4.05M Sell
56,586
-8,536
-13% -$634K 1.92% 24
2016
Q3 		$5.15M Sell
65,122
-8,345
-11% -$678K 2.36% 14
2016
Q2 		$6.13M Buy
+73,467
New +$6.52M 2.94% 12
2015
Q4 		$7.61M Sell
75,152
-4,300
-5% -$447K 3.47% 7
2015
Q3 		$7.8M Sell
79,452
-2,920
-4% -$324K 3.72% 7
2015
Q2 		$9.64M Buy
+82,372
New +$9M 3.86% 5
2014
Q4 		$8.02M Sell
85,107
-1,868
-2% -$193K 3.45% 7
2014
Q3 		$9.26M Buy
86,975
+1,265
+1% +$124K 4.16% 3
2014
Q2 		$7.11M Buy
85,710
+270
+0.3% +$21K 3.32% 7
2014
Q1 		$6.05M Buy
85,440
+1,000
+1% +$78.4K 2.87% 9
2013
Q4 		$6.34M Buy
84,440
+1,220
+1% +$84.9K 3% 9
2013
Q3 		$5.23M Buy
+83,220
New +$4.97M 2.8% 9

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rosenblum Silverman Sutton's GILD Position: Q2 2017 in Review

Rosenblum Silverman Sutton sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 9,945 shares — an estimated $675K sold.

Rosenblum Silverman Sutton first reported a position in GILD in Q3 2013 and held it in 13 quarters. The position peaked at $9.64M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Rosenblum Silverman Sutton reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Rosenblum Silverman Sutton sold 9,945 Gilead Sciences shares in Q2 2017, an estimated $675K.
  • Rosenblum Silverman Sutton first reported a position in Gilead Sciences in Q3 2013 and held it in 13 quarters.
  • Rosenblum Silverman Sutton's Gilead Sciences position peaked at $9.64M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Rosenblum Silverman Sutton's 13F filing for Q2 2017, filed 9 Aug 2017.